Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | 171.17%743 | -90.04%53 | -99.79%563 | -58.67%851 | -58.67%851 | -83.03%274 | -98.57%532 | 7,440.26%273.79K | -95.05%2.06K | -95.05%2.06K |
| -Cash and cash equivalents | 171.17%743 | -90.04%53 | -99.79%563 | -58.67%851 | -58.67%851 | -83.03%274 | -98.57%532 | 7,440.26%273.79K | -95.05%2.06K | -95.05%2.06K |
| Receivables | -99.80%500 | 0.00%500 | -11.66%500 | -11.66%500 | -11.66%500 | 136.08%250.5K | -99.53%500 | -99.47%566 | -99.47%566 | -99.47%566 |
| -Accounts receivable | 0.00%500 | 0.00%500 | -11.66%500 | -11.66%500 | -11.66%500 | -91.82%500 | -91.82%500 | -90.92%566 | -90.92%566 | -90.92%566 |
| -Notes receivable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --0 |
| -Other receivables | ---- | ---- | ---- | ---- | ---- | --250K | ---- | ---- | ---- | ---- |
| Prepaid assets | -34.71%17.31K | -47.91%13.81K | -47.91%13.81K | 96.65%24.97K | 96.65%24.97K | 108.73%26.51K | 108.73%26.51K | -20.67%26.51K | -80.15%12.7K | -80.15%12.7K |
| Total current assets | -93.31%18.55K | -47.85%14.36K | -95.06%14.87K | 71.78%26.33K | 71.78%26.33K | 130.25%277.28K | -82.36%27.54K | 109.98%300.86K | -92.76%15.33K | -92.76%15.33K |
| Non current assets | ||||||||||
| Investments and advances | --0 | -84.51%95.5K | -73.94%95.5K | -73.26%95.5K | -73.26%95.5K | -40.55%366.5K | 3.79%616.5K | -39.87%366.5K | -41.41%357.1K | -41.41%357.1K |
| -Long term equity investment | --0 | --95.5K | --95.5K | -73.26%95.5K | -73.26%95.5K | ---- | ---- | ---- | --357.1K | --357.1K |
| Total non current assets | --0 | -84.51%95.5K | -73.94%95.5K | -73.26%95.5K | -73.26%95.5K | -40.55%366.5K | 3.79%616.5K | -39.87%366.5K | -41.41%357.1K | -41.41%357.1K |
| Total assets | -97.12%18.55K | -82.94%109.86K | -83.46%110.37K | -67.29%121.83K | -67.29%121.83K | -12.64%643.78K | -14.14%644.04K | -11.35%667.36K | -54.65%372.43K | -54.65%372.43K |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Current debt and capital lease obligation | --3.5K | --98K | --95.5K | --29.5K | --29.5K | ---- | ---- | ---- | ---- | ---- |
| -Current debt | --3.5K | --98K | --95.5K | --29.5K | --29.5K | ---- | ---- | ---- | ---- | ---- |
| Payables | -26.73%568.38K | 53.13%1.08M | 110.81%1.02M | 86.92%849.27K | 86.92%849.27K | 89.47%775.71K | 63.05%706.66K | 59.36%484.53K | 60.99%454.34K | 60.99%454.34K |
| -accounts payable | -26.73%568.38K | 53.13%1.08M | 110.81%1.02M | 86.92%849.27K | 86.92%849.27K | 89.47%775.71K | 63.05%706.66K | 59.36%484.53K | 60.99%454.34K | 60.99%454.34K |
| Current accrued expenses | --30K | --20K | 22.34%45.88K | 22.22%55K | 22.22%55K | --0 | --0 | -37.50%37.5K | -25.00%45K | -25.00%45K |
| Current liabilities | -22.41%601.88K | 69.83%1.2M | 122.75%1.16M | 87.00%933.77K | 87.00%933.77K | 83.86%775.71K | 55.86%706.66K | 14.91%522.03K | 15.70%499.34K | 15.70%499.34K |
| Non current liabilities | ||||||||||
| Derivative product liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --0 |
| Total non current liabilities | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Total liabilities | -22.41%601.88K | 69.83%1.2M | 122.75%1.16M | 87.00%933.77K | 87.00%933.77K | 83.86%775.71K | 55.86%706.66K | -21.16%522.03K | -21.17%499.34K | -21.17%499.34K |
| Shareholders'equity | ||||||||||
| Share capital | 4.46%13.43M | 0.00%12.86M | 0.00%12.86M | 1.86%12.86M | 1.86%12.86M | 1.79%12.86M | 2.58%12.86M | 5.08%12.86M | 3.16%12.62M | 3.16%12.62M |
| -common stock | 4.46%13.43M | 0.00%12.86M | 0.00%12.86M | 1.86%12.86M | 1.86%12.86M | 1.79%12.86M | 2.58%12.86M | 5.08%12.86M | 3.16%12.62M | 3.16%12.62M |
| Retained earnings | -7.06%-15.54M | -7.11%-15.47M | -8.41%-15.43M | -8.34%-15.19M | -8.34%-15.19M | -5.74%-14.51M | -5.45%-14.44M | -5.09%-14.24M | -5.78%-14.02M | -5.78%-14.02M |
| Gains losses not affecting retained earnings | 0.00%1.52M | 0.00%1.52M | 0.00%1.52M | 19.61%1.52M | 19.61%1.52M | 8.14%1.52M | 8.21%1.52M | 8.77%1.52M | 5.29%1.27M | 5.29%1.27M |
| Total stockholders'equity | -342.15%-583.33K | -1,640.98%-1.09M | -824.15%-1.05M | -539.74%-811.94K | -539.74%-811.94K | -141.88%-131.93K | -121.10%-62.62K | 60.32%145.33K | -167.58%-126.92K | -167.58%-126.92K |
| Total equity | -342.15%-583.33K | -1,640.98%-1.09M | -824.15%-1.05M | -539.74%-811.94K | -539.74%-811.94K | -141.88%-131.93K | -121.10%-62.62K | 60.32%145.33K | -167.58%-126.92K | -167.58%-126.92K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.